After a behind-the-scenes squabble spilled out into the public, Sarepta has replaced the chairman of its board and reaffirmed its support of CEO Chris Garabedian, looking to move on from an embarrassing distraction and focus on its lead drug program.

…read more

Source: Sarepta looks to quiet controversy with a boardroom shakeup


0 No comments